Cost-effectiveness of treatment for chronic hepatitis C infection - Reply

被引：2
|
作者：
Salomon, JA [1 ]
Goldie, SJ [1 ]
机构：
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 290卷 / 15期
关键词：
D O I：
10.1001/jama.290.15.1994-a
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1994 / 1994
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C
    Brogan, Anita J.
    Talbird, Sandra E.
    Thompson, James R.
    Miller, Jeffrey D.
    Rubin, Jaime
    Deniz, Baris
    [J]. PLOS ONE, 2014, 9 (03):
  • [42] Relative cost-effectiveness for the retreatment of chronic hepatitis C.
    Saab, S
    Han, SH
    Martin, P
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1483 - A1483
  • [43] A review of the cost-effectiveness analysis of treatment with direct acting antivirals for chronic hepatitis C
    Arai, Kuniaki Arai
    Yamashita, Tatsuya
    Takata, Noboru
    Horii, Richa
    Terashima, Takeshi
    Kitahara, Masaaki
    Sunagozaka, Hajime
    Shimakami, Tetsuro
    Kaneko, Shuichi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 383 - 383
  • [44] COST-EFFECTIVENESS ANALYSIS OF DACLATASVIR WITH ASUNAPREVIR IN TREATMENT OF CHRONIC HEPATITIS C IN THE RUSSIAN FEDERATION
    Yagudina, R.
    Kulikov, A.
    Babiy, V. V.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A415 - A415
  • [45] Treatment of patients with chronic hepatitis C: Doubts about a cost-effectiveness study - Response
    Joliot, E
    Vanlemmens, C
    Miguet, JP
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (04): : 337 - 338
  • [46] THE COST-EFFECTIVENESS OF ALPHA-INTERFERON IN THE TREATMENT OF CHRONIC ACTIVE HEPATITIS-C
    SHIELL, A
    BRIGGS, A
    FARRELL, GC
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (05) : 268 - 272
  • [47] Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B
    Crowley, SJ
    Tognarini, D
    Desmond, PV
    Lees, M
    [J]. PHARMACOECONOMICS, 2000, 17 (05) : 409 - 427
  • [48] Cost-effectiveness of lamivudine for the treatment of chronic hepatitis B in Canada
    Haiderali, AM
    Villa, K
    Schrammel, P
    [J]. HEPATOLOGY, 1999, 30 (04) : 347A - 347A
  • [49] Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
    Steven J. Crowley
    David Tognarini
    Paul V. Desmond
    Michael Lees
    [J]. PharmacoEconomics, 2000, 17 : 409 - 427
  • [50] COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN ARGENTINA
    Garcia Marti, S.
    Alcaraz, A.
    Valanzasca, P.
    Garay Ulises, U.
    McMullen, M.
    Rey Ares, L.
    Peirano, I
    Bessone, F.
    Fainboim, H.
    Gadano, A.
    Galdame, O.
    Vujacich, C.
    Caporale, J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A692 - A692
12345